Movement Alert｜WuXi XDC Rises 3.05% in Regular Trading, Analyst Recommendation and Subsidiary Order Continue to Boost Sentiment

Market Focus

Jun 24

On June 24, WuXi XDC rose 3.05% in regular trading, trading at HK$50.75/share, with turnover of HK$23.62 million. This marks the third consecutive trading day of gains for the stock, which has climbed from HK$47.36 on June 18.

On the news front, BOCOM International recently issued a research report highlighting WuXi XDC as a top pick among leading players in high-growth biotech tracks with attractive valuations. Meanwhile, CMB International also recommended the stock, noting the innovative drug and medical device export trend remains intact and that biomedical has been positioned as a pillar industry. Additionally, subsidiary Dongyao Pharma signed a process development and manufacturing service agreement with WuXi Biologics on June 16 to deliver 10 batches of monoclonal antibody intermediates totaling RMB 19 million, aimed at deepening technical know-how and enhancing process capabilities.

Within the Life Sciences Tools and Services sector, the overall sector strengthened. Among individual stocks, Genscript Biotech up 5.24%, WuXi AppTec up 3.82%, WuXi Biologics up 1.73%, forming broad sector resonance.

(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

1
2
3
4
5
6
7
8
9
10

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1194651622"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1194651622\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1194651622?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-24 09:38","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1194651622","market":"us","top_or_hot":-1,"title":"Movement Alert｜WuXi XDC Rises 3.05% in Regular Trading, Analyst Recommendation and Subsidiary Order Continue to Boost Sentiment","media":"Market Focus","content":"<p><p>On June 24, WuXi XDC rose 3.05% in regular trading, trading at HK$50.75/share, with turnover of HK$23.62 million. This marks the third consecutive trading day of gains for the stock, which has climbed from HK$47.36 on June 18.</p><p>On the news front, BOCOM International recently issued a research report highlighting WuXi XDC as a top pick among leading players in high-growth biotech tracks with attractive valuations. Meanwhile, CMB International also recommended the stock, noting the innovative drug and medical device export trend remains intact and that biomedical has been positioned as a pillar industry. Additionally, subsidiary Dongyao Pharma signed a process development and manufacturing service agreement with WuXi Biologics on June 16 to deliver 10 batches of monoclonal antibody intermediates totaling RMB 19 million, aimed at deepening technical know-how and enhancing process capabilities.</p><p>Within the Life Sciences Tools and Services sector, the overall sector strengthened. Among individual stocks, Genscript Biotech up 5.24%, WuXi AppTec up 3.82%, WuXi Biologics up 1.73%, forming broad sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Movement Alert｜WuXi XDC Rises 3.05% in Regular Trading, Analyst Recommendation and Subsidiary Order Continue to Boost Sentiment</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nMovement Alert｜WuXi XDC Rises 3.05% in Regular Trading, Analyst Recommendation and Subsidiary Order Continue to Boost Sentiment\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1054767329\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Market Focus </p>\n<p class=\"h-time\">2026-06-24 09:38</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p><p>On June 24, WuXi XDC rose 3.05% in regular trading, trading at HK$50.75/share, with turnover of HK$23.62 million. This marks the third consecutive trading day of gains for the stock, which has climbed from HK$47.36 on June 18.</p><p>On the news front, BOCOM International recently issued a research report highlighting WuXi XDC as a top pick among leading players in high-growth biotech tracks with attractive valuations. Meanwhile, CMB International also recommended the stock, noting the innovative drug and medical device export trend remains intact and that biomedical has been positioned as a pillar industry. Additionally, subsidiary Dongyao Pharma signed a process development and manufacturing service agreement with WuXi Biologics on June 16 to deliver 10 batches of monoclonal antibody intermediates totaling RMB 19 million, aimed at deepening technical know-how and enhancing process capabilities.</p><p>Within the Life Sciences Tools and Services sector, the overall sector strengthened. Among individual stocks, Genscript Biotech up 5.24%, WuXi AppTec up 3.82%, WuXi Biologics up 1.73%, forming broad sector resonance.</p><p>(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)</p></p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"02268","symbol_name":"药明合联","start_time":0,"source_url":"","article_id":"1194651622","we_media_id":"1054767329","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1194651622","pubTimestamp":1782265097,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Market Focus","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1054767329","head_image":"https://static.tigerbbs.com/51943b2858f75e05ca2ebb144b4e626a"},"summary":"On June 24, WuXi XDC rose 3.05% in regular trading, trading at HK$50.75/share, with turnover of HK$23.62 million. This marks the third consecutive trading day of gains for the stock, which has...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"02268":"药明合联"},"translate_title":"动向提示|无锡XDC常规交易上涨3.05%分析师推荐和子公司订单继续提振人气","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"02268":1},"content_text":"On June 24, WuXi XDC rose 3.05% in regular trading, trading at HK$50.75/share, with turnover of HK$23.62 million. This marks the third consecutive trading day of gains for the stock, which has climbed from HK$47.36 on June 18.On the news front, BOCOM International recently issued a research report highlighting WuXi XDC as a top pick among leading players in high-growth biotech tracks with attractive valuations. Meanwhile, CMB International also recommended the stock, noting the innovative drug and medical device export trend remains intact and that biomedical has been positioned as a pillar industry. Additionally, subsidiary Dongyao Pharma signed a process development and manufacturing service agreement with WuXi Biologics on June 16 to deliver 10 batches of monoclonal antibody intermediates totaling RMB 19 million, aimed at deepening technical know-how and enhancing process capabilities.Within the Life Sciences Tools and Services sector, the overall sector strengthened. Among individual stocks, Genscript Biotech up 5.24%, WuXi AppTec up 3.82%, WuXi Biologics up 1.73%, forming broad sector resonance.(The above content is based on publicly available market information, generated by a program or algorithm, and is intended solely as a stock movement alert. It does not constitute investment advice or a basis for trading decisions.)","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}